Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

Theranostics in Neuroendocrine Tumors: A New Era of Precision Medicine

Session Description

This session will provide the latest insights on the application of radioisotopes in patients with endocrine and other tumors. The field of nuclear imaging and therapy has expanded vastly and the newest developments will be discussed.

Presentations in This Video

Chair

Mark Gurnell, BSc (Hons), MBBS, MA (MedEd), PhD, FAcadMed, FRCP

University of Cambridge

Theranostics in Neuroendocrine Tumors: A New Era of Precision Medicine

Erik Mittra, MD, PhD

Oregon Health & Science University

Novel approaches for molecular imaging of prostate adenocarcinoma and neuroendocrine prostate cancer

Robert Flavell, MD, PhD

University of California, San Francisco

Peptide Receptor Radionucleotide Therapy in Thyroid Cancer

Joanna Klubo-Gwiezdzinska, MD,PhD MHSc

NIH-NIDDK

Related Media